Late therapeutic intervention with a respiratory syncytial virus L‐protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium

BACKGROUND AND PURPOSE: Effective anti‐respiratory syncytial virus (RSV) agents are still not available for clinical use. Current major targets are virus surface proteins, such as a fusion protein involved in viral entry, but agents effective after RSV infection is established are required. Here we...

Descripción completa

Detalles Bibliográficos
Autores principales: Brookes, Daniel W, Coates, Matthew, Allen, Heather, Daly, Leah, Constant, Samuel, Huang, Song, Hows, Mark, Davis, Amanda, Cass, Lindsey, Ayrton, John, Knowles, Ian, Strong, Pete, Rapeport, Garth, Ito, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980447/
https://www.ncbi.nlm.nih.gov/pubmed/29579332
http://dx.doi.org/10.1111/bph.14221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980447/
https://www.ncbi.nlm.nih.gov/pubmed/29579332
http://dx.doi.org/10.1111/bph.14221

Ejemplares similares